Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE3.8000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.7900/ 1
- Ask / Lots4.5000/ 10
- Open / Previous Close3.8500 / 3.8000
- Day Range
- 52 Week Range
- Volume415,341
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 3835 | 3.83 |
| 09:34 ET | 109 | 3.87 |
| 09:36 ET | 200 | 3.81 |
| 09:52 ET | 2000 | 3.8 |
| 09:54 ET | 5740 | 3.8 |
| 09:56 ET | 200 | 3.8 |
| 09:57 ET | 4600 | 3.81 |
| 09:59 ET | 1299 | 3.83 |
| 10:01 ET | 100 | 3.835 |
| 10:06 ET | 300 | 3.85 |
| 10:08 ET | 1786 | 3.855 |
| 10:10 ET | 300 | 3.85 |
| 10:12 ET | 2300 | 3.87 |
| 10:17 ET | 1100 | 3.875 |
| 10:28 ET | 300 | 3.87 |
| 10:30 ET | 100 | 3.875 |
| 10:32 ET | 100 | 3.875 |
| 10:33 ET | 206 | 3.87 |
| 10:35 ET | 225 | 3.8601 |
| 10:37 ET | 100 | 3.87 |
| 10:39 ET | 100 | 3.87 |
| 10:42 ET | 100 | 3.87 |
| 10:44 ET | 3690 | 3.85 |
| 10:46 ET | 311 | 3.85 |
| 10:48 ET | 100 | 3.85 |
| 10:50 ET | 1800 | 3.86 |
| 10:51 ET | 700 | 3.86 |
| 10:53 ET | 8237 | 3.87 |
| 10:55 ET | 213 | 3.86 |
| 10:57 ET | 700 | 3.86 |
| 11:00 ET | 7904 | 3.89 |
| 11:02 ET | 100 | 3.89 |
| 11:04 ET | 100 | 3.89 |
| 11:06 ET | 111 | 3.89 |
| 11:08 ET | 3383 | 3.9 |
| 11:09 ET | 1036 | 3.89 |
| 11:11 ET | 9200 | 3.9 |
| 11:15 ET | 1048 | 3.93 |
| 11:18 ET | 1100 | 3.92 |
| 11:20 ET | 300 | 3.935 |
| 11:22 ET | 200 | 3.9233 |
| 11:27 ET | 300 | 3.92 |
| 11:29 ET | 4613 | 3.9 |
| 11:31 ET | 1200 | 3.9 |
| 11:33 ET | 200 | 3.9 |
| 11:36 ET | 100 | 3.9 |
| 11:38 ET | 400 | 3.9 |
| 11:40 ET | 26023 | 3.8599 |
| 11:42 ET | 13317 | 3.9 |
| 11:44 ET | 1500 | 3.8962 |
| 11:47 ET | 646 | 3.9 |
| 11:49 ET | 400 | 3.9 |
| 11:51 ET | 212 | 3.9 |
| 11:56 ET | 400 | 3.8929 |
| 12:03 ET | 1300 | 3.87 |
| 12:07 ET | 400 | 3.87 |
| 12:14 ET | 3701 | 3.92 |
| 12:18 ET | 475 | 3.92 |
| 12:21 ET | 100 | 3.93 |
| 12:25 ET | 100 | 3.935 |
| 12:41 ET | 100 | 3.935 |
| 12:43 ET | 100 | 3.92 |
| 12:48 ET | 600 | 3.93 |
| 12:50 ET | 5484 | 3.9226 |
| 12:54 ET | 12100 | 3.93 |
| 12:56 ET | 23791 | 3.92 |
| 12:57 ET | 200 | 3.915 |
| 12:59 ET | 1900 | 3.9 |
| 01:01 ET | 2254 | 3.87 |
| 01:03 ET | 24998 | 3.89 |
| 01:06 ET | 23654 | 3.855 |
| 01:08 ET | 16783 | 3.845 |
| 01:10 ET | 17766 | 3.8 |
| 01:12 ET | 3920 | 3.83 |
| 01:14 ET | 3300 | 3.81 |
| 01:17 ET | 12923 | 3.8 |
| 01:19 ET | 400 | 3.798 |
| 01:24 ET | 275 | 3.79 |
| 01:30 ET | 513 | 3.809 |
| 01:33 ET | 3182 | 3.795 |
| 01:35 ET | 300 | 3.8 |
| 01:37 ET | 11373 | 3.77 |
| 01:39 ET | 100 | 3.79 |
| 01:42 ET | 112 | 3.79 |
| 01:44 ET | 220 | 3.79 |
| 01:46 ET | 2244 | 3.77 |
| 01:48 ET | 100 | 3.77 |
| 01:50 ET | 100 | 3.77 |
| 01:51 ET | 15245 | 3.79 |
| 01:53 ET | 100 | 3.78 |
| 01:55 ET | 303 | 3.78 |
| 01:57 ET | 110 | 3.78 |
| 02:00 ET | 208 | 3.78 |
| 02:02 ET | 104 | 3.78 |
| 02:04 ET | 111 | 3.78 |
| 02:06 ET | 109 | 3.78 |
| 02:08 ET | 201 | 3.78 |
| 02:11 ET | 204 | 3.79 |
| 02:18 ET | 2681 | 3.7701 |
| 02:22 ET | 107 | 3.77 |
| 02:26 ET | 100 | 3.77 |
| 02:27 ET | 454 | 3.79 |
| 02:31 ET | 101 | 3.77 |
| 02:36 ET | 135 | 3.78 |
| 02:40 ET | 100 | 3.77 |
| 02:44 ET | 104 | 3.77 |
| 02:45 ET | 100 | 3.78 |
| 02:47 ET | 117 | 3.77 |
| 02:49 ET | 395 | 3.78 |
| 02:51 ET | 103 | 3.77 |
| 02:58 ET | 200 | 3.77 |
| 03:02 ET | 103 | 3.77 |
| 03:05 ET | 1728 | 3.8 |
| 03:07 ET | 100 | 3.8 |
| 03:09 ET | 305 | 3.8096 |
| 03:12 ET | 1836 | 3.7967 |
| 03:14 ET | 103 | 3.79 |
| 03:16 ET | 133 | 3.8 |
| 03:20 ET | 100 | 3.8 |
| 03:21 ET | 900 | 3.775 |
| 03:23 ET | 200 | 3.775 |
| 03:25 ET | 140 | 3.775 |
| 03:30 ET | 1300 | 3.77 |
| 03:32 ET | 200 | 3.77 |
| 03:34 ET | 100 | 3.78 |
| 03:36 ET | 1117 | 3.78 |
| 03:38 ET | 4389 | 3.78 |
| 03:41 ET | 506 | 3.79 |
| 03:45 ET | 1498 | 3.785 |
| 03:48 ET | 1635 | 3.8 |
| 03:50 ET | 348 | 3.79 |
| 03:52 ET | 387 | 3.79 |
| 03:54 ET | 2068 | 3.81 |
| 03:56 ET | 7063 | 3.79 |
| 03:57 ET | 3667 | 3.77 |
| 03:59 ET | 22165 | 3.8 |
May 2, 2024
Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform, from 4:30PM ET on Thursday May 02, 2024 by Dow Jones
4:30PM ET on Thursday May 02, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 201.2M | -0.8x | --- |
Galectin Therapeutics Inc | 200.6M | -4.4x | --- |
Acumen Pharmaceuticals Inc | 204.3M | -3.3x | --- |
Omeros Corp | 204.5M | -1.3x | --- |
Prelude Therapeutics Inc | 197.2M | -2.2x | --- |
Elevation Oncology Inc | 195.6M | -3.4x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $199.6M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.47 |
EPS | $-4.97 |
Book Value | $5.06 |
P/E Ratio | -0.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
